TARA Smart Money
Protara Therapeutics, Inc.
1W: -3.5%
1M: -24.0%
3M: -35.2%
YTD: -54.1%
1Y: -51.6%
3Y: +73.9%
5Y: -65.3%
$2.47
+0.12 (+5.11%)
Pre-Market: $2.88 (+0.41, +16.80%)
Weekly Expected Move ±9.1%
$2
$2
$2
$3
$3
Credit Risk of going bust: lower than 58% of companies Debt: 1.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.7%), Protara Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $146.0M.
Distance to default 6.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 74.6%; Altman Z'' 7.46. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.7%), Protara Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $146.0M.
Distance to default 6.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 74.6%; Altman Z'' 7.46. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026139
Institutions Holding
+4 vs prior
120.9%
Ownership
-41.58%
28
New
51
Increased
45
Reduced
17
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Shefferman Jesse | officer: ceo and president | G-Gift | 4,000 | $— | $0 | Filing |
| 2026-06-30 | Shefferman Jesse | officer: ceo and president | G-Gift | 7,000 | $— | $0 | Filing |
| 2026-06-30 | Shefferman Jesse | officer: ceo and president | G-Gift | 14,000 | $— | $0 | Filing |
| 2026-06-30 | Shefferman Jesse | officer: ceo and president | G-Gift | 5,000 | $— | $0 | Filing |
| 2026-06-29 | Shefferman Jesse | officer: ceo and president | S-Sale | 215,687 | $4.09 | $882K | Filing |
| 2026-06-02 | CONKLING WILLIAM | officer: chief commercial officer | F-Tax Withholding | 6,008 | $4.34 | $26K | Filing |
| 2026-04-08 | Zummo Jacqueline | officer: chief r&d officer | S-Sale | 1,134 | $5.40 | $6K | Filing |
| 2026-01-26 | Zummo Jacqueline | officer: chf scientific operations off | F-Tax Withholding | 3,724 | $6.67 | $25K | Filing |
| 2026-01-26 | Fabbio Patrick | officer: chief financial officer | F-Tax Withholding | 3,261 | $6.67 | $22K | Filing |
| 2026-01-26 | Fry Hannah | officer: vp, controller | F-Tax Withholding | 1,457 | $6.67 | $10K | Filing |
| 2026-01-26 | Shefferman Jesse | officer: ceo and president | F-Tax Withholding | 8,732 | $6.67 | $58K | Filing |
| 2026-01-20 | Fabbio Patrick | officer: chief financial officer | F-Tax Withholding | 3,063 | $5.60 | $17K | Filing |
| 2026-01-20 | Fry Hannah | officer: vp, controller | F-Tax Withholding | 2,132 | $5.60 | $12K | Filing |
| 2026-01-20 | Zummo Jacqueline | officer: chf scientific operations off | F-Tax Withholding | 6,578 | $5.60 | $37K | Filing |
| 2026-01-20 | Shefferman Jesse | officer: ceo and president | F-Tax Withholding | 16,322 | $5.60 | $91K | Filing |
| 2026-01-16 | Zummo Jacqueline | officer: chf scientific operations off | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-01-16 | Shefferman Jesse | officer: ceo and president | A-Grant/Award | 87,000 | $— | $0 | Filing |
| 2026-01-16 | Nicacio Leonardo Viana | officer: chief medical officer | A-Grant/Award | 26,000 | $— | $0 | Filing |
| 2026-01-16 | Fry Hannah | officer: vp, controller | A-Grant/Award | 9,500 | $— | $0 | Filing |
| 2026-01-16 | Fabbio Patrick | officer: chief financial officer | A-Grant/Award | 28,000 | $— | $0 | Filing |
| 2026-01-16 | CONKLING WILLIAM | officer: chief commercial officer | A-Grant/Award | 26,000 | $— | $0 | Filing |
| 2025-06-27 | Shefferman Jesse | officer: ceo and president | G-Gift | 10,200 | $— | $0 | Filing |
| 2025-06-27 | Shefferman Jesse | officer: ceo and president | G-Gift | 3,367 | $— | $0 | Filing |
| 2025-06-26 | Shefferman Jesse | officer: ceo and president | G-Gift | 3,400 | $— | $0 | Filing |
| 2025-06-26 | Shefferman Jesse | officer: ceo and president | G-Gift | 1,700 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 4,696,709 | $18M | +4,696,709 | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,663,499 | $14M | +268,531 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 3,101,166 | $12M | +269,958 | 2026-06-30 | Filing |
| Velan Capital Investment Management LP | 2,844,652 | $11M | +10,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,300,133 | $9M | +181,115 | 2026-06-30 | Filing |
| Blackstone Inc. | 2,265,514 | $9M | — | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 2,220,000 | $8M | +2,220,000 | 2026-06-30 | Filing |
| Sio Capital Management, LLC | 1,921,872 | $7M | -47,967 | 2026-06-30 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 1,752,115 | $7M | — | 2026-06-30 | Filing |
| Integral Health Asset Management, LLC | 1,500,000 | $6M | -250,000 | 2026-06-30 | Filing |
| 5AM Venture Management, LLC | 1,369,782 | $5M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,326,246 | $5M | +149,046 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,232,365 | $5M | +163,807 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,068,295 | $4M | +63,153 | 2026-06-30 | Filing |
| Qube Research & Technologies Ltd | 1,045,516 | $4M | +868,512 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 1,026,691 | $4M | +1,026,691 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 971,614 | $4M | — | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 940,512 | $4M | — | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 882,179 | $3M | -43,739 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 701,021 | $3M | +650,290 | 2026-06-30 | Filing |